Annual EBITDA:
-$146.31M+$42.96M(+22.70%)Summary
- As of today (October 3, 2025), ADPT annual EBITDA is -$146.31 million, with the most recent change of +$42.96 million (+22.70%) on December 31, 2024.
- During the last 3 years, ADPT annual EBITDA has risen by +$47.03 million (+24.33%).
- ADPT annual EBITDA is now -286.67% below its all-time high of -$37.84 million, reached on December 31, 2017.
Performance
ADPT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$18.14M+$4.05M(+18.25%)Summary
- As of today (October 3, 2025), ADPT quarterly EBITDA is -$18.14 million, with the most recent change of +$4.05 million (+18.25%) on June 30, 2025.
- Over the past year, ADPT quarterly EBITDA has increased by +$20.41 million (+52.94%).
- ADPT quarterly EBITDA is now -55.24% below its all-time high of -$11.69 million, reached on March 31, 2018.
Performance
ADPT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$91.22M+$20.41M(+18.28%)Summary
- As of today (October 3, 2025), ADPT TTM EBITDA is -$91.22 million, with the most recent change of +$20.41 million (+18.28%) on June 30, 2025.
- Over the past year, ADPT TTM EBITDA has increased by +$88.63 million (+49.28%).
- ADPT TTM EBITDA is now -680.53% below its all-time high of -$11.69 million, reached on March 31, 2018.
Performance
ADPT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ADPT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +22.7% | +52.9% | +49.3% |
| 3Y3 Years | +24.3% | +61.3% | +57.3% |
| 5Y5 Years | -107.2% | +48.0% | +26.8% |
ADPT EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +24.3% | at high | +70.3% | at high | +54.5% |
| 5Y | 5-Year | -107.2% | +24.3% | at high | +70.3% | at high | +57.3% |
| All-Time | All-Time | -286.7% | +24.3% | -55.2% | +70.3% | -680.5% | +57.3% |
ADPT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$18.14M(-18.3%) | -$91.22M(-18.3%) |
| Mar 2025 | - | -$22.19M(-15.7%) | -$111.63M(-13.3%) |
| Dec 2024 | -$146.31M(-22.7%) | -$26.32M(+7.1%) | -$128.76M(-21.3%) |
| Sep 2024 | - | -$24.57M(-36.3%) | -$163.50M(-9.1%) |
| Jun 2024 | - | -$38.55M(-2.0%) | -$179.85M(-0.0%) |
| Mar 2024 | - | -$39.33M(-35.6%) | -$179.85M(-5.0%) |
| Dec 2023 | -$189.27M(+8.0%) | -$61.06M(+49.3%) | -$189.27M(+18.7%) |
| Sep 2023 | - | -$40.91M(+6.1%) | -$159.51M(+1.0%) |
| Jun 2023 | - | -$38.55M(-20.9%) | -$157.88M(-5.0%) |
| Mar 2023 | - | -$48.75M(+55.7%) | -$166.22M(-5.1%) |
| Dec 2022 | -$175.21M(-9.4%) | -$31.30M(-20.3%) | -$175.21M(-12.6%) |
| Sep 2022 | - | -$39.28M(-16.2%) | -$200.42M(-6.2%) |
| Jun 2022 | - | -$46.89M(-18.8%) | -$213.61M(+0.0%) |
| Mar 2022 | - | -$57.74M(+2.2%) | -$213.58M(+9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$193.34M(+33.9%) | -$56.51M(+7.7%) | -$194.45M(+8.1%) |
| Sep 2021 | - | -$52.47M(+12.0%) | -$179.83M(+10.8%) |
| Jun 2021 | - | -$46.86M(+21.4%) | -$162.26M(+7.9%) |
| Mar 2021 | - | -$38.61M(-7.8%) | -$150.31M(+4.1%) |
| Dec 2020 | -$144.34M(+104.5%) | -$41.89M(+20.0%) | -$144.34M(+15.9%) |
| Sep 2020 | - | -$34.91M(-0.0%) | -$124.57M(+17.9%) |
| Jun 2020 | - | -$34.91M(+7.0%) | -$105.66M(+24.3%) |
| Mar 2020 | - | -$32.64M(+47.6%) | -$84.98M(+20.4%) |
| Dec 2019 | -$70.60M(+61.3%) | -$22.11M(+38.3%) | -$70.60M(+15.7%) |
| Sep 2019 | - | -$15.99M(+12.3%) | -$61.04M(+35.5%) |
| Jun 2019 | - | -$14.23M(-22.1%) | -$45.05M(+46.2%) |
| Mar 2019 | - | -$18.26M(+45.5%) | -$30.81M(+27.1%) |
| Dec 2018 | -$43.76M(+15.6%) | -$12.55M(+7.4%) | -$24.24M(+107.4%) |
| Mar 2018 | - | -$11.69M | -$11.69M |
| Dec 2017 | -$37.84M | - | - |
FAQ
- What is Adaptive Biotechnologies Corporation annual EBITDA?
- What is the all-time high annual EBITDA for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation annual EBITDA year-on-year change?
- What is Adaptive Biotechnologies Corporation quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation quarterly EBITDA year-on-year change?
- What is Adaptive Biotechnologies Corporation TTM EBITDA?
- What is the all-time high TTM EBITDA for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation TTM EBITDA year-on-year change?
What is Adaptive Biotechnologies Corporation annual EBITDA?
The current annual EBITDA of ADPT is -$146.31M
What is the all-time high annual EBITDA for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high annual EBITDA is -$37.84M
What is Adaptive Biotechnologies Corporation annual EBITDA year-on-year change?
Over the past year, ADPT annual EBITDA has changed by +$42.96M (+22.70%)
What is Adaptive Biotechnologies Corporation quarterly EBITDA?
The current quarterly EBITDA of ADPT is -$18.14M
What is the all-time high quarterly EBITDA for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high quarterly EBITDA is -$11.69M
What is Adaptive Biotechnologies Corporation quarterly EBITDA year-on-year change?
Over the past year, ADPT quarterly EBITDA has changed by +$20.41M (+52.94%)
What is Adaptive Biotechnologies Corporation TTM EBITDA?
The current TTM EBITDA of ADPT is -$91.22M
What is the all-time high TTM EBITDA for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high TTM EBITDA is -$11.69M
What is Adaptive Biotechnologies Corporation TTM EBITDA year-on-year change?
Over the past year, ADPT TTM EBITDA has changed by +$88.63M (+49.28%)